Featured Research

from universities, journals, and other organizations

Patients Benefit From University Of Florida Epilepsy Research Leading To FDA Approval Of Vagus Nerve Stimulator

Date:
September 5, 1997
Source:
University of Florida
Summary:
The stimulator interrupts epileptic seizures by sending an electrical stimulus to the brain and is used to treat patients who aren't helped by anticonvulsant medications.

Related Articles


GAINESVILLE, Fla.---The road to independence has been a long one for Carolyn Short.

The 43-year-old Palm Springs resident now pilots a 1997 light green Saturn, but for years she relied on others to transport her around town, because the epileptic seizures that wracked her body daily prevented her from driving herself.

Her freedom came in the form of a small pacemaker-like device known as the vagus nerve stimulator, which just last month received federal Food and Drug Administration approval.

The stimulator interrupts epileptic seizures by sending an electrical stimulus to the brain and is used to treat patients who aren't helped by anticonvulsant medications.

Researchers at the University of Florida and Gainesville Veterans Affairs Medical Center were among the first to study the device in patients at Shands Hospital at UF and at the VAMC, tracking its effectiveness and safety since 1989. In many patients, the number of seizures has decreased with the treatment, says Dr. Basim Uthman, a neurologist at the UF Brain Institute and Gainesville's Veterans Affairs Medical Center.

Other patients may have significant reductions in both the intensity and duration of seizures, and report the vagus nerve stimulator helps them "snap out" of a seizure faster, Uthman said.

Short had small seizures from the time she was a baby, but when she entered her 20s she started having up to 15 convulsions a day -- many of them classified as grand mal, which caused her to lose consciousness.

"My life changed because I had to be dependent on people. I always hated asking for rides," Short recalled. "I didn't have my parents take me a lot of places because I didn't want to bother them."

In 1990 she received the vagus stimulator. The device, about the size of a stopwatch, is inserted through a small incision under the skin of the chest and is programmed to emit timed electrical impulses through wires that tunnel to the left side of the neck, then spiral around the vagus nerve. The operation takes up to two hours and is done on an outpatient basis, said Uthman, associate chief of the VAMC neurology service, director of the VAMC's clinical neurophysiology lab and associate professor of neurology at UF.

"Right away my seizures weren't as severe as before, they stopped faster and I felt better afterward," Short said.

During the first several years after Short received the implant, physicians adjusted how frequently the device fired and switched her medication. She has now been seizure-free for more than two years.

Called the "wandering nerve," the vagus is the longest of 12 cranial nerves and sends messages to many organs, including the heart, lung and stomach. This nerve also communicates with a portion of the brain stem linked to regions thought to be involved in certain epileptic seizures.

Vagus nerve stimulation appears to work by calming "hyperexcited" nerve cells and reverting brain activity to its normal pattern. It also may enhance the release of chemical building blocks that bolster cellular membranes in the central nervous system, adding stability to neurons and making them less excitable.

Because seizures occur unpredictably, physicians program the device to fire every few minutes and hope the impulses will hit just as a seizure starts. The impulses also may interfere with some events that lead to a seizure and thus prevent it from happening. Patients also can trigger the device with a magnet if they sense a seizure is imminent.

Patients with the implants, who remain on antiseizure medications, may notice their voice vibrate or detect a mild tingling in their necks during stimulation. They also may cough during stimulation for a short time after they first receive the implant.

The Epilepsy Foundation of America estimates about 2.5 million Americans have epilepsy. Of the nearly 150,000 people who develop the disorder each year, at least 10 to 20 percent suffer from uncontrolled seizures. Epilepsy is the world's second-most-prevalent neurological disorder, affecting an estimated 50 million people worldwide.

Sherry Douglas, a 33-year-old substitute teacher from Live Oak, also has benefited from the device. Douglas had up to 10 seizures a month, some very strong.

Since receiving the stimulator, she is down to two or three a month and has cut back on her medications.

"I no longer have grand mal seizures and the seizures I do have are shorter and not as intense," said Douglas, whose epilepsy stems from a head injury she suffered while falling out of a bed when she was a baby. "So even though I know I might have a seizure I don't have that fear like I used to if I feel one coming on.

"I'm on a lot less medicine and that was my goal," she added. "I'm real sensitive to medications -- they would make me sleepy and weak. The vagal stimulator doesn't have any side effects like that."

-------------------------------------------

Recent UF Health Science Center news releases also are available on the UF Health Science Center Communications home page. Point your browser to http://www.vpha.health.ufl.edu/hscc/index.html

For the UF Health Science Center topic/expert list, point your browser to http://www.health.ufl.edu/hscc/experts.html

For Shands Hospital news releases, point your browser to http://www.shands.com/framehmpg.html


Story Source:

The above story is based on materials provided by University of Florida. Note: Materials may be edited for content and length.


Cite This Page:

University of Florida. "Patients Benefit From University Of Florida Epilepsy Research Leading To FDA Approval Of Vagus Nerve Stimulator." ScienceDaily. ScienceDaily, 5 September 1997. <www.sciencedaily.com/releases/1997/09/970905151034.htm>.
University of Florida. (1997, September 5). Patients Benefit From University Of Florida Epilepsy Research Leading To FDA Approval Of Vagus Nerve Stimulator. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/1997/09/970905151034.htm
University of Florida. "Patients Benefit From University Of Florida Epilepsy Research Leading To FDA Approval Of Vagus Nerve Stimulator." ScienceDaily. www.sciencedaily.com/releases/1997/09/970905151034.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins